Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Overall“
Suchtreffer
Begriffe & Kennungen
Bonviva · 4.8 · In a two-year study in postmenopausal women with osteoporosis (BM 16549) the overall safety of Bonviva 150 mg
Eintrag öffnenBonviva · 4.8 · In the pivotal two-year study in postmenopausal women with osteoporosis (BM16550), the overall safety of intra
Eintrag öffnenBrief Psychiatric Rating Scale
Eintrag öffnenBrilique · 4.8 · Bleeding Bleeding findings in PLATO Overall outcome of bleeding rates in the PLATO study are shown in Table 2.
Eintrag öffnenBrilique · 4.8 · Bleeding Bleeding findings in PLATO Overall outcome of bleeding rates in the PLATO study are shown in Table 2.
Eintrag öffnenBrilique · 4.8 · Bleeding Bleeding findings in PLATO Overall outcome of bleeding rates in the PLATO study are shown in Table 2.
Eintrag öffnenBrilique · 4.8 · Bleeding findings in PEGASUS Overall outcome of bleeding events in the PEGASUS study are shown in Table 3.
Eintrag öffnenBrilique · 4.8 · Bleeding findings in PEGASUS Overall outcome of bleeding events in the PEGASUS study are shown in Table 3.
Eintrag öffnenBrilique · 4.8 · Bleeding findings in PEGASUS Overall outcome of bleeding events in the PEGASUS study are shown in Table 3.
Eintrag öffnenBrilique · 4.8 · Table 2 – Analysis of overall bleeding events, Kaplan-Meier estimates at 12 months (PLATO)
Eintrag öffnenBrilique · 4.8 · Table 2 – Analysis of overall bleeding events, Kaplan-Meier estimates at 12 months (PLATO)
Eintrag öffnenBrilique · 4.8 · Table 2 – Analysis of overall bleeding events, Kaplan-Meier estimates at 12 months (PLATO)
Eintrag öffnenBrilique · 4.8 · Table 3 – Analysis of overall bleeding events, Kaplan-Meier estimates at 36 months (PEGASUS)
Eintrag öffnenBrilique · 4.8 · Table 3 – Analysis of overall bleeding events, Kaplan-Meier estimates at 36 months (PEGASUS)
Eintrag öffnenBrilique · 4.8 · Table 3 – Analysis of overall bleeding events, Kaplan-Meier estimates at 36 months (PEGASUS)
Eintrag öffnenByooviz · 4.8 · In the wet AMD phase III studies, the overall frequency of non-ocular haemorrhages, an adverse event potential
Eintrag öffnenByooviz · 4.8 · In the wet AMD phase III studies, the overall frequency of non-ocular haemorrhages, an adverse event potential
Eintrag öffnenCapecitabine Accord · 4.8 · The overall safety profile of capecitabine is based on data from over 3,000 patients treated with capecitabine
Eintrag öffnenCapecitabine Teva · 4.8 · The overall safety profile of capecitabine is based on data from over 3000 patients treated with capecitabine
Eintrag öffnenCerezyme · 4.8 · Symptoms suggestive of hypersensitivity have been noted, overall, in approximately 3% of the patients. Onset o
Eintrag öffnen